Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 05-2022 | 02-2022 | 11-2021 | 08-2021 | 05-2021 | |
| Sales | 100 | 31 | 14 | 31 | 204 |
| Cost of Goods | 19 | 6 | 6 | 20 | 60 |
| Gross Profit | 81 | 24 | 8 | 11 | 144 |
| Operating Expenses | 2,518 | 1,479 | 2,017 | 1,334 | 2,771 |
| Operating Income | -2,418 | -1,449 | -2,004 | -1,303 | -2,567 |
| Pre-tax Income | -2,418 | -1,449 | -2,004 | -1,303 | -2,567 |
| Net Income Continuous | -2,418 | -1,449 | -2,004 | -1,303 | -2,567 |
| Minority Interests | -35 | -23 | -10 | -134 | N/A |
| Net Income | $-2,383 | $-1,426 | $-1,993 | $-1,169 | $-2,567 |
| EPS Basic Total Ops | -0.41 | -0.25 | -0.35 | -0.30 | -0.50 |
| EPS Basic Continuous Ops | -0.41 | -0.25 | -0.35 | -0.31 | -0.50 |
| EPS Diluted Total Ops | -0.41 | -0.25 | -0.35 | -0.30 | -0.50 |
| EPS Diluted Continuous Ops | -0.41 | -0.25 | -0.35 | -0.31 | -0.50 |
| EBITDA(a) | $-2,394 | $-1,423 | $-1,976 | $-1,239 | $-2,539 |